🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Scientists in the Dream3D Lab expanded their cutting-edge cell imaging tool to visualize how CAR-T and other immunotherapies work in liquid tumors – such as the blood cancer, leukemia – in real time. Their methods published in Nature Protocols. Read more: research.prinsesmaximacentrum.nl/en/news-events…

Our researchers are exploring a new type of immunotherapy with so-called 'MR1 T-cells'. They might be able to treat specific childhood cancers, such as leukemia and aggressive brain tumors. Read more: bit.ly/44r8TIJ

Pediatric oncology specialists gather this week at the annual SIOPE 🎗️ congress. Knowledge shared from the Máxima includes: nursing research, nausea, organoids, prevention of hearing loss, exercise care and quality of life. research.prinsesmaximacentrum.nl/en/news-events…

🧬 Exploring oncolytic viruses as a potential treatment for children's brain tumors. Early research at Princess Máxima Center with Erasmus MC shows promise for targeting tumors with specific genetic profiles. More studies needed. Learn more: research.prinsesmaximacentrum.nl/en/news-events…

Today is Clinical Trials Day. 127 WMO clinical trials have started at the Máxima since its opening. 'The 120 employees of the TDC design and coordinate the often international studies and analyze the collected data' bit.ly/clinicaltrials…

Organoid modelling of #CNSdevelopment in health #neurodevelopmentaldisorders. ISDN Speakers: Benedetta Artegiani PrinsesMáximaCentrum, Alexandre Baffet @Alex_Baffet Institut Curie, Fikri Birey Emory University, Silvia Velasco Murdoch Children's Research Institute (MCRI). Submit abstracts bit.ly/ISDN2024

Is it possible to determine the type of kidney tumor from MRI scans? Soon to be PhD Justine van der Beek investigated this question. She also looked at how this could help to provide the child after the MRI scan with the most appropriate treatment. research.prinsesmaximacentrum.nl/en/news-events…

📢Online today 👉A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery #FluorescenceGuidedSurgery #LiveOrganoids By B. Jeremiasse, Anne Rios & colleagues PrinsesMáximaCentrum 🗞️doi.org/10.1038/s44321…

Researchers have found the most common cause of recurrent T-LBL. These NOTCH1 gene fusions are linked to increased CCL17 levels in the blood and can be used as a biomarker for HR T-LBL.  This brings personalized treatment one step closer. research.prinsesmaximacentrum.nl/en/news-events…

🔬 A new 3D model aids surgeons in operating on children with kidney cancer at the Princess Máxima Center. This technology allows for more precise and safer surgeries.🎗️⚕️ research.prinsesmaximacentrum.nl/en/news-events…

🌟 Trots op onderzoek Astrid van Barneveld! Ze wint de Conquer Cancer Merit Award voor haar onderzoek in naar process mining in de kinderoncologie. 👏🎉 Lees meer: research.prinsesmaximacentrum.nl/nl/news-events… #ASCO #ConquerCancer

🌟 Proud of Astrid van Barneveld! She wins the Conquer Cancer Merit Award for her research into process mining in paediatric oncology. 👏🎉 Read more: research.prinsesmaximacentrum.nl/en/news-events… #ASCO #ConquerCancer

Dr. Lideke van der Steeg at the Princess Máxima Center gets €600K from Kenneth @[email protected] to develop 3D models for precise surgeries on kids with hard-to-find tumors. This tech aims to make operations faster, safer, and easier, improving recovery and quality of life. bit.ly/3Lp7SYS

Researchers at the Máxima developed a system using organoids to test dyes for fluorescence-guided surgery, to enhance precision and reducing damage to healthy tissue. This innovation boosts surgery accuracy for both child and adult cancers. 🔗 Read: research.prinsesmaximacentrum.nl/en/news-events…

🔬 Cause of leukemia after cancer treatment discovered! Researchers at the Máxima Center found how chemotherapy causes genetic changes leading to leukemia in some children. This helps to better understand, monitor, and prevent secondary cancers. research.prinsesmaximacentrum.nl/en/news-events…

Great news! In children with a KMT2A abnormality, leukemia cells appear to respond to treatment with a menin inhibitor. Previously, 1 in 10 children with relapsed or resistant acute KMT2A leukemia went into remission. Now almost 1 in 4. Read: research.prinsesmaximacentrum.nl/en/news-events…

New insights into T-ALL from the Princess Máxima Center! Researchers reveal how T-cell acute lymphoblastic leukemia develops, leading to targeted treatments for children. Vera Poort: "This is key to understanding the disease." research.prinsesmaximacentrum.nl/en/news-events… #ChildhoodCancer #Research

The spatial organization of immune cells in the bone marrow in children with acute myeloid leukemia (AML) has been mapped for the first time. Nearly one in three children with AML has many immune cells in the bone marrow. Read: research.prinsesmaximacentrum.nl/en/news-events…

Researchers from the Máxima have found a possible new treatment for atypical teratoid rhabdoid tumors (ATRT) in the brain. Lab research with new research models is promising. Read: research.prinsesmaximacentrum.nl/en/news-events…

Meet Ryan (8). He has bone cancer and knows more than you'd ever wish for a child. His story highlights the complexity and impact of childhood cancer treatment. This must be improved. Read more about our campaign on bit.ly/4gaAMdM #CCAM